IV Iron Infusion Therapy

Safe intravenous iron infusion therapy administered by the experienced healthcare team at Cottesloe Medical Centre. Indicated for confirmed iron deficiency anaemia or low ferritin where oral iron is ineffective or poorly tolerated. A GP consultation and blood tests confirming iron deficiency are required prior to infusion. Monitored in-clinic with a 30-minute post-infusion observation period.

Cottesloe Medical Centre explicitly offers intravenous iron infusion therapy as a core clinical service, administered by experienced GPs and nursing staff within the clinic's 16-consulting-room facility at 525 Stirling Highway, Cottesloe, Western Australia. IV iron infusion is indicated for patients with confirmed iron deficiency — verified by blood tests showing low serum ferritin, low transferrin saturation, or frank iron deficiency anaemia (low haemoglobin with microcytic red cells) — in whom oral iron supplementation has failed, is contraindicated, is poorly tolerated due to gastrointestinal side effects (constipation, nausea, dark stools), or where rapid iron repletion is clinically necessary (e.g. pre-operatively, in chronic fatigue with very low ferritin, or in inflammatory bowel disease where intestinal iron absorption is impaired). The most commonly used IV iron preparations in Australian GP clinics include ferric carboxymaltose (Ferinject) and low-molecular-weight iron dextran, which can deliver a large dose of iron — typically 500–1000 mg — in a single infusion session of thirty to sixty minutes, compared to months of daily oral supplementation. At Cottesloe Medical Centre, the pathway begins with a GP consultation to assess clinical indication and order pre-infusion pathology via the co-located Clinipath service; once iron deficiency is confirmed, the infusion is scheduled and conducted with appropriate monitoring, including a mandatory thirty-minute post-infusion observation period to monitor for hypersensitivity reactions (rare with modern iron formulations but a required safety protocol). Common beneficiaries include women with heavy menstrual bleeding, athletes with sports anaemia, patients with gastrointestinal bleeding or malabsorption disorders, vegetarians and vegans, and patients with chronic kidney disease or inflammatory conditions causing functional iron deficiency. The co-location of Clinipath pathology at the same premises makes pre-infusion testing and dose calculation efficient, often completing within a single morning appointment for new patients.